The European Technology Platform on Nanomedicine (ETPN) proudly endorses the Joint Statement for an Ambitious FP10, published by EARTO and Business Europe. Supported by 110 European organizations, this statement calls for a significant increase in the RD&I budget and emphasizes the importance of pan-European collaborative research. The ETPN highlights the critical role of continued investment in nanomedicine to support innovative diagnostics, treatments, and nano-enabled vaccines. Discover more about our commitment to fostering European nanotechnology in healthcare.

Discover the launch of the ‘We Are ETPN’ video series, spotlighting the innovative work of NanoVation Therapeutics™ in RNA therapeutics and nucleic acid delivery. Join us on this journey to connect with the leading minds in nanomedicine.

The project proposal NANOSPRESSO-NL will be funded by the Dutch Research Council with a 9M€ budget for the next five years. NANOSPRESSO-NL will develop a disruptive technology to make lipid nanoparticles for the delivery of RNA and DNA at the bedside, initially for orphan diseases. The ETPN will be participating in this great innovative Nanomedicine project, notably to optimize its communication and dissemination activities.